Wilson R E, Orth D N, Nicholson W E, Mount C D, Bertagna X Y
J Clin Endocrinol Metab. 1981 Jul;53(1):1-9. doi: 10.1210/jcem-53-1-1.
Disagreement exists concerning the relative contributions to total plasma immunoreactive human lipotropin (hLPH) made by h beta LPH and its amino-terminal fragment, h gamma LPH [h beta LPH-(1-58)]. Using an antiserum (R1547) which requires the free COOH-terminal Asp58 residue of h gamma LPH for full affinity and reacts only 1% as well with h beta LPH and antisera (R3 and G106) that react with both LPHs, we examined gel chromatography eluate fractions of plasma extracts from one normal subject under basal conditions and another after metyrapone administration, of plasma or plasma extracts from patients with ACTH/LPH hypersecretion of various causes, of an extract two normal pituitary glands, and an extract of an ectopic ACTH/LPH-secreting tumor. Immunoreactive h gamma LPH was always a major, frequently the predominant, and sometimes the only immunoreactive LPH observed. We also observed in plasma or tissue of two patients with ectopic ACTH/LPH syndrome a peptide whose immunoreactivity and apparent molecular size were consistent with those of octadecapeptide human beta MSH, a molecule that is not thought to exist in normal man. These studies demonstrate that h gamma LPH is a major LPH component in plasma and tissues and indicate that the h gamma LPH RIA provides a reliable estimate of the h gamma LPH concentration in plasma without prior chromatography.
关于人β促脂解素(hβLPH)及其氨基末端片段人γ促脂解素[hβLPH-(1-58)]对血浆总免疫反应性人促脂解素(hLPH)的相对贡献存在分歧。使用一种抗血清(R1547),它需要hγLPH的游离羧基末端天冬氨酸58残基才能具有完全亲和力,与hβLPH的反应性仅为1%,以及与两种促脂解素都反应的抗血清(R3和G106),我们检测了一名正常受试者在基础条件下以及另一名服用甲吡酮后的血浆提取物的凝胶色谱洗脱级分、各种原因导致促肾上腺皮质激素/促脂解素分泌过多患者的血浆或血浆提取物、两个正常垂体的提取物以及一个异位促肾上腺皮质激素/促脂解素分泌肿瘤的提取物。免疫反应性hγLPH始终是主要的,经常是占主导地位的,有时是唯一观察到的免疫反应性促脂解素。我们还在两名异位促肾上腺皮质激素/促脂解素综合征患者的血浆或组织中观察到一种肽,其免疫反应性和表观分子大小与十八肽人β促黑素一致,而正常人体内一般认为不存在这种分子。这些研究表明,hγLPH是血浆和组织中的主要促脂解素成分,并表明hγLPH放射免疫测定法无需事先进行色谱分析就能可靠地估计血浆中hγLPH的浓度。